Piper Sandler initiated coverage on IDEXX Labs with a new price target
$IDXX
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Health Care
Piper Sandler initiated coverage of IDEXX Labs with a rating of Overweight and set a new price target of $440.00